| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocyte Membrane | 21 | 2011 | 438 | 1.910 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 15 | 2013 | 150 | 1.080 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2019 | 606 | 0.810 |
Why?
|
| Cytoskeleton | 7 | 2012 | 1178 | 0.670 |
Why?
|
| Ankyrins | 5 | 2010 | 123 | 0.670 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 7 | 2009 | 453 | 0.520 |
Why?
|
| Cell Membrane | 15 | 2013 | 3642 | 0.490 |
Why?
|
| Nitric Oxide Synthase | 7 | 2005 | 911 | 0.470 |
Why?
|
| Membrane Lipids | 10 | 1996 | 241 | 0.470 |
Why?
|
| Capacity Building | 1 | 2017 | 265 | 0.460 |
Why?
|
| Diffusion | 15 | 2011 | 810 | 0.440 |
Why?
|
| Calcium | 16 | 2010 | 5792 | 0.410 |
Why?
|
| Receptors, Transferrin | 5 | 2005 | 300 | 0.410 |
Why?
|
| Elliptocytosis, Hereditary | 2 | 2011 | 29 | 0.410 |
Why?
|
| Microscopy, Fluorescence | 16 | 2010 | 2628 | 0.410 |
Why?
|
| Membrane Proteins | 19 | 2015 | 7868 | 0.400 |
Why?
|
| Spectrin | 5 | 2010 | 176 | 0.400 |
Why?
|
| Erythrocytes, Abnormal | 4 | 2011 | 121 | 0.400 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2015 | 3667 | 0.390 |
Why?
|
| Genetic Variation | 4 | 2015 | 6611 | 0.390 |
Why?
|
| Erythrocytes | 9 | 1999 | 2411 | 0.370 |
Why?
|
| Computational Biology | 2 | 2014 | 3567 | 0.370 |
Why?
|
| Pseudomonas aeruginosa | 6 | 2009 | 1277 | 0.360 |
Why?
|
| Introns | 2 | 2011 | 965 | 0.360 |
Why?
|
| International Cooperation | 1 | 2017 | 1434 | 0.350 |
Why?
|
| Endothelium, Vascular | 13 | 2007 | 4424 | 0.340 |
Why?
|
| Complement C3b | 1 | 2009 | 98 | 0.320 |
Why?
|
| Research Design | 2 | 2015 | 6210 | 0.320 |
Why?
|
| T-Lymphocytes | 11 | 2010 | 10254 | 0.320 |
Why?
|
| Disease | 1 | 2014 | 675 | 0.320 |
Why?
|
| Faculty, Medical | 1 | 2017 | 1227 | 0.310 |
Why?
|
| Endocytosis | 5 | 2009 | 951 | 0.310 |
Why?
|
| Cell Adhesion Molecules | 4 | 2008 | 1612 | 0.300 |
Why?
|
| Caveolin 1 | 2 | 2009 | 255 | 0.300 |
Why?
|
| Membrane Fluidity | 10 | 1996 | 67 | 0.300 |
Why?
|
| Cell Adhesion | 12 | 2008 | 3093 | 0.280 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 3 | 2011 | 381 | 0.270 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 4 | 2007 | 35 | 0.270 |
Why?
|
| Multifactorial Inheritance | 1 | 2014 | 1422 | 0.260 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2008 | 2568 | 0.250 |
Why?
|
| Genome, Human | 4 | 2016 | 4441 | 0.250 |
Why?
|
| Receptors, Cell Surface | 5 | 2007 | 2815 | 0.250 |
Why?
|
| Models, Statistical | 3 | 2014 | 5098 | 0.250 |
Why?
|
| Aquaporins | 2 | 2013 | 176 | 0.250 |
Why?
|
| Schistosoma mansoni | 3 | 1993 | 156 | 0.240 |
Why?
|
| Models, Genetic | 2 | 2014 | 3445 | 0.240 |
Why?
|
| Calmodulin | 2 | 2003 | 239 | 0.240 |
Why?
|
| Jurkat Cells | 5 | 2010 | 740 | 0.240 |
Why?
|
| Electricity | 2 | 1996 | 173 | 0.240 |
Why?
|
| Cell Line | 25 | 2013 | 15567 | 0.230 |
Why?
|
| Kinetics | 15 | 2006 | 6287 | 0.220 |
Why?
|
| Pseudomonas Infections | 4 | 2009 | 623 | 0.210 |
Why?
|
| Health Personnel | 1 | 2017 | 3387 | 0.210 |
Why?
|
| Pituitary Gland | 3 | 1995 | 635 | 0.210 |
Why?
|
| Protein Interaction Mapping | 1 | 2006 | 621 | 0.210 |
Why?
|
| Lipid Bilayers | 7 | 2013 | 377 | 0.210 |
Why?
|
| Alleles | 4 | 2022 | 6893 | 0.210 |
Why?
|
| Cystic Fibrosis | 2 | 2009 | 1292 | 0.200 |
Why?
|
| MicroRNAs | 4 | 2013 | 3792 | 0.200 |
Why?
|
| Phospholipids | 6 | 2000 | 778 | 0.200 |
Why?
|
| Fluorescent Dyes | 13 | 2006 | 1928 | 0.190 |
Why?
|
| Essential Tremor | 1 | 2004 | 160 | 0.190 |
Why?
|
| Biomedical Research | 1 | 2017 | 3464 | 0.190 |
Why?
|
| Fluorescein-5-isothiocyanate | 9 | 2006 | 220 | 0.190 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 4780 | 0.180 |
Why?
|
| Molecular Probes | 3 | 2007 | 309 | 0.170 |
Why?
|
| Recombinant Proteins | 5 | 2008 | 6507 | 0.170 |
Why?
|
| Membrane Microdomains | 4 | 2009 | 205 | 0.170 |
Why?
|
| Genome-Wide Association Study | 4 | 2016 | 12790 | 0.170 |
Why?
|
| Electromagnetic Fields | 2 | 1999 | 290 | 0.160 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 5363 | 0.160 |
Why?
|
| Microscopy, Video | 4 | 2001 | 241 | 0.160 |
Why?
|
| Gene Frequency | 3 | 2016 | 3621 | 0.160 |
Why?
|
| Calcium Signaling | 2 | 2003 | 736 | 0.160 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2013 | 434 | 0.150 |
Why?
|
| Intercellular Junctions | 2 | 2015 | 198 | 0.150 |
Why?
|
| Humans | 98 | 2022 | 767040 | 0.150 |
Why?
|
| Cattle | 10 | 2012 | 3813 | 0.150 |
Why?
|
| Epithelial Cells | 3 | 2009 | 3698 | 0.150 |
Why?
|
| Proteins | 4 | 2011 | 6001 | 0.150 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 812 | 0.150 |
Why?
|
| Protein Transport | 6 | 2015 | 1944 | 0.150 |
Why?
|
| Biophysical Phenomena | 5 | 1999 | 318 | 0.150 |
Why?
|
| Electric Stimulation | 2 | 2004 | 1736 | 0.140 |
Why?
|
| RNA, Small Interfering | 8 | 2015 | 3427 | 0.140 |
Why?
|
| Integrins | 2 | 2012 | 840 | 0.140 |
Why?
|
| Lysophosphatidylcholines | 2 | 1988 | 77 | 0.140 |
Why?
|
| Biophysics | 5 | 1999 | 376 | 0.140 |
Why?
|
| Genomics | 4 | 2014 | 5924 | 0.140 |
Why?
|
| Macrophage Activation | 1 | 2000 | 554 | 0.140 |
Why?
|
| Lactase | 1 | 2016 | 72 | 0.130 |
Why?
|
| Cytomegalovirus | 2 | 2013 | 751 | 0.130 |
Why?
|
| Fibronectins | 2 | 2000 | 722 | 0.130 |
Why?
|
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 2 | 1995 | 34 | 0.130 |
Why?
|
| Anemia, Sickle Cell | 4 | 2007 | 1065 | 0.130 |
Why?
|
| RNA Splicing | 2 | 2011 | 903 | 0.130 |
Why?
|
| Contact Inhibition | 1 | 2015 | 46 | 0.130 |
Why?
|
| Thyrotropin-Releasing Hormone | 2 | 1995 | 139 | 0.130 |
Why?
|
| Fluorescence Polarization | 4 | 1998 | 139 | 0.130 |
Why?
|
| Major Histocompatibility Complex | 2 | 2016 | 879 | 0.130 |
Why?
|
| Nuclear Lamina | 2 | 2013 | 46 | 0.130 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2022 | 1362 | 0.120 |
Why?
|
| Models, Biological | 8 | 2012 | 9464 | 0.120 |
Why?
|
| Biological Transport | 7 | 2002 | 2084 | 0.120 |
Why?
|
| Animals | 43 | 2015 | 168965 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 7 | 2000 | 6106 | 0.120 |
Why?
|
| Actomyosin | 1 | 2015 | 114 | 0.120 |
Why?
|
| Blood Proteins | 3 | 1999 | 1190 | 0.120 |
Why?
|
| Algorithms | 4 | 2012 | 14098 | 0.120 |
Why?
|
| Lymphocyte Activation | 7 | 2006 | 5499 | 0.120 |
Why?
|
| Freeze Fracturing | 2 | 2009 | 68 | 0.120 |
Why?
|
| Rwanda | 1 | 2017 | 671 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2014 | 16036 | 0.120 |
Why?
|
| Zygote | 2 | 1996 | 117 | 0.120 |
Why?
|
| Neurofibromin 2 | 1 | 2015 | 269 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type III | 6 | 2005 | 706 | 0.110 |
Why?
|
| Erythrocyte Aggregation | 2 | 1996 | 35 | 0.110 |
Why?
|
| Receptor Aggregation | 3 | 2008 | 72 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 3 | 2015 | 1326 | 0.110 |
Why?
|
| Protein Binding | 6 | 2008 | 9327 | 0.110 |
Why?
|
| Electric Stimulation Therapy | 1 | 2000 | 635 | 0.110 |
Why?
|
| Genome | 2 | 2013 | 1752 | 0.110 |
Why?
|
| Calcium Channels | 5 | 2004 | 622 | 0.110 |
Why?
|
| Phosphorylation | 13 | 2013 | 8310 | 0.110 |
Why?
|
| Cell Movement | 3 | 2006 | 5203 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2014 | 18063 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 6 | 2009 | 3738 | 0.110 |
Why?
|
| Anonymous Testing | 1 | 2013 | 10 | 0.110 |
Why?
|
| Microsatellite Repeats | 2 | 2013 | 784 | 0.110 |
Why?
|
| Bacterial Proteins | 5 | 2007 | 3834 | 0.100 |
Why?
|
| Fertilization | 1 | 1994 | 197 | 0.100 |
Why?
|
| Virus Release | 1 | 2013 | 35 | 0.100 |
Why?
|
| Colchicine | 1 | 1994 | 256 | 0.100 |
Why?
|
| Vinblastine | 1 | 1994 | 482 | 0.100 |
Why?
|
| Names | 1 | 2013 | 54 | 0.100 |
Why?
|
| Membranes | 1 | 1993 | 164 | 0.100 |
Why?
|
| HLA Antigens | 3 | 1988 | 1334 | 0.100 |
Why?
|
| Umbilical Veins | 3 | 2007 | 423 | 0.100 |
Why?
|
| Diffusion of Innovation | 1 | 2017 | 724 | 0.100 |
Why?
|
| Water | 1 | 1999 | 1419 | 0.100 |
Why?
|
| Cells, Cultured | 14 | 2015 | 18989 | 0.100 |
Why?
|
| Integrin alpha6 | 1 | 2012 | 30 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2012 | 2887 | 0.100 |
Why?
|
| Cell Compartmentation | 2 | 2011 | 383 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2002 | 4167 | 0.100 |
Why?
|
| Selection, Genetic | 1 | 2016 | 877 | 0.100 |
Why?
|
| Chromosomes, Human, Y | 1 | 2013 | 163 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 1271 | 0.100 |
Why?
|
| Estradiol | 1 | 1999 | 1951 | 0.100 |
Why?
|
| Receptors, LDL | 1 | 1994 | 492 | 0.100 |
Why?
|
| Respiratory Mucosa | 2 | 2007 | 437 | 0.090 |
Why?
|
| Microscopy, Electron | 3 | 2009 | 2551 | 0.090 |
Why?
|
| Receptors, Immunologic | 3 | 2012 | 1418 | 0.090 |
Why?
|
| Evolution, Molecular | 2 | 2010 | 1893 | 0.090 |
Why?
|
| Viruses | 1 | 2015 | 371 | 0.090 |
Why?
|
| Program Development | 1 | 2017 | 1298 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2007 | 1965 | 0.090 |
Why?
|
| Sequence Deletion | 1 | 1995 | 1494 | 0.090 |
Why?
|
| Biopolymers | 3 | 1997 | 182 | 0.090 |
Why?
|
| Blood Cells | 1 | 2013 | 309 | 0.090 |
Why?
|
| Blastocyst | 1 | 1994 | 432 | 0.090 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2013 | 384 | 0.090 |
Why?
|
| Cytoplasmic Granules | 2 | 2005 | 574 | 0.090 |
Why?
|
| Models, Molecular | 3 | 2010 | 5388 | 0.090 |
Why?
|
| Signal Transduction | 9 | 2012 | 23621 | 0.090 |
Why?
|
| Glycosylphosphatidylinositols | 2 | 2009 | 88 | 0.090 |
Why?
|
| Macrophages | 3 | 2012 | 5785 | 0.080 |
Why?
|
| Receptors, Complement | 1 | 2010 | 254 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 1512 | 0.080 |
Why?
|
| Endothelial Cells | 4 | 2012 | 3582 | 0.080 |
Why?
|
| Microscopy, Confocal | 6 | 2012 | 1969 | 0.080 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2013 | 426 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 1312 | 0.080 |
Why?
|
| Complement System Proteins | 1 | 2013 | 738 | 0.080 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2011 | 446 | 0.080 |
Why?
|
| Leukocytes | 2 | 2008 | 2034 | 0.080 |
Why?
|
| Uterine Rupture | 1 | 1990 | 67 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 1996 | 2001 | 0.080 |
Why?
|
| Erythrocyte Aging | 1 | 2009 | 52 | 0.080 |
Why?
|
| Retinoblastoma Protein | 1 | 2013 | 670 | 0.080 |
Why?
|
| Rotation | 3 | 1996 | 515 | 0.080 |
Why?
|
| Genes, BRCA1 | 1 | 2013 | 753 | 0.080 |
Why?
|
| Molecular Conformation | 2 | 2010 | 540 | 0.080 |
Why?
|
| Neutrophils | 2 | 2006 | 3779 | 0.080 |
Why?
|
| Cholesterol | 4 | 1996 | 2905 | 0.080 |
Why?
|
| Biological Evolution | 1 | 2015 | 1075 | 0.080 |
Why?
|
| Luminescent Proteins | 2 | 2003 | 839 | 0.080 |
Why?
|
| Phosphoproteins | 2 | 2008 | 2448 | 0.080 |
Why?
|
| Oocytes | 1 | 1994 | 1168 | 0.080 |
Why?
|
| RNA Precursors | 1 | 2010 | 196 | 0.080 |
Why?
|
| Capillary Permeability | 1 | 2012 | 772 | 0.080 |
Why?
|
| Computer Simulation | 2 | 2014 | 6260 | 0.080 |
Why?
|
| Spherocytosis, Hereditary | 2 | 1999 | 83 | 0.080 |
Why?
|
| Hydrogen Peroxide | 1 | 2012 | 740 | 0.080 |
Why?
|
| Cytomegalovirus Infections | 2 | 2013 | 836 | 0.080 |
Why?
|
| Virus Diseases | 1 | 2015 | 722 | 0.080 |
Why?
|
| Optical Tweezers | 1 | 2009 | 83 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 832 | 0.080 |
Why?
|
| Aminoglycosides | 1 | 2009 | 161 | 0.080 |
Why?
|
| Membrane Glycoproteins | 4 | 1994 | 3702 | 0.080 |
Why?
|
| Likelihood Functions | 1 | 2011 | 996 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 4648 | 0.070 |
Why?
|
| Microspheres | 2 | 2010 | 774 | 0.070 |
Why?
|
| CDC2 Protein Kinase | 1 | 2009 | 212 | 0.070 |
Why?
|
| Protein Deficiency | 1 | 2008 | 57 | 0.070 |
Why?
|
| Lipoproteins, LDL | 1 | 1991 | 640 | 0.070 |
Why?
|
| Molecular Mimicry | 1 | 2009 | 212 | 0.070 |
Why?
|
| Vault Ribonucleoprotein Particles | 1 | 2007 | 11 | 0.070 |
Why?
|
| Leiomyoma | 2 | 1990 | 644 | 0.070 |
Why?
|
| Chlorides | 2 | 2009 | 666 | 0.070 |
Why?
|
| Transfection | 7 | 2005 | 5753 | 0.070 |
Why?
|
| Heterozygote | 2 | 2013 | 2794 | 0.070 |
Why?
|
| Transferases | 1 | 2007 | 71 | 0.070 |
Why?
|
| COS Cells | 3 | 2005 | 1135 | 0.070 |
Why?
|
| Exodeoxyribonucleases | 1 | 2008 | 191 | 0.070 |
Why?
|
| Interferon-gamma | 3 | 1996 | 3154 | 0.070 |
Why?
|
| DNA | 3 | 2012 | 7210 | 0.070 |
Why?
|
| Complement Activation | 1 | 2009 | 447 | 0.070 |
Why?
|
| Cortactin | 1 | 2006 | 28 | 0.070 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 2006 | 40 | 0.070 |
Why?
|
| Corneal Ulcer | 1 | 2008 | 125 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2012 | 3760 | 0.070 |
Why?
|
| Photobleaching | 1 | 2006 | 29 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2014 | 22254 | 0.070 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2007 | 350 | 0.070 |
Why?
|
| Cyclic GMP | 1 | 2007 | 394 | 0.070 |
Why?
|
| Antigens, CD | 5 | 2008 | 4032 | 0.070 |
Why?
|
| Fluoresceins | 3 | 1995 | 235 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2012 | 2472 | 0.070 |
Why?
|
| Markov Chains | 1 | 2010 | 976 | 0.070 |
Why?
|
| Subcellular Fractions | 2 | 2004 | 526 | 0.070 |
Why?
|
| Placenta Accreta | 1 | 1990 | 242 | 0.060 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2007 | 260 | 0.060 |
Why?
|
| Antibody Affinity | 1 | 2006 | 251 | 0.060 |
Why?
|
| Surface Plasmon Resonance | 1 | 2006 | 268 | 0.060 |
Why?
|
| Calpain | 1 | 2006 | 146 | 0.060 |
Why?
|
| Stress, Physiological | 2 | 2005 | 1407 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2019 | 3591 | 0.060 |
Why?
|
| RNA, Messenger | 5 | 2009 | 12793 | 0.060 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2008 | 661 | 0.060 |
Why?
|
| Photochemistry | 3 | 1996 | 239 | 0.060 |
Why?
|
| Antigen-Presenting Cells | 3 | 2006 | 960 | 0.060 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2008 | 481 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 2744 | 0.060 |
Why?
|
| Epithelium, Corneal | 1 | 2008 | 247 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2014 | 6331 | 0.060 |
Why?
|
| Eye Infections, Bacterial | 1 | 2008 | 239 | 0.060 |
Why?
|
| Protein Conformation | 3 | 2006 | 3948 | 0.060 |
Why?
|
| Xanthenes | 2 | 1995 | 71 | 0.060 |
Why?
|
| Ion Channel Gating | 2 | 1999 | 428 | 0.060 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2005 | 415 | 0.060 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 3 | 1991 | 897 | 0.060 |
Why?
|
| Hemolysis | 1 | 1986 | 417 | 0.060 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2005 | 178 | 0.060 |
Why?
|
| Caveolins | 1 | 2004 | 102 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 3 | 2008 | 2063 | 0.060 |
Why?
|
| Cations | 2 | 2002 | 239 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2013 | 2047 | 0.060 |
Why?
|
| Type C Phospholipases | 1 | 2004 | 287 | 0.060 |
Why?
|
| Mice | 18 | 2015 | 81912 | 0.060 |
Why?
|
| Uterine Neoplasms | 2 | 1990 | 1424 | 0.060 |
Why?
|
| Cadherins | 1 | 2008 | 903 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2003 | 201 | 0.050 |
Why?
|
| Acceleration | 1 | 2004 | 189 | 0.050 |
Why?
|
| Vasodilator Agents | 1 | 2007 | 988 | 0.050 |
Why?
|
| Erythropoietin | 1 | 2008 | 718 | 0.050 |
Why?
|
| Mitochondrial Swelling | 1 | 2002 | 15 | 0.050 |
Why?
|
| RNA Stability | 1 | 2005 | 319 | 0.050 |
Why?
|
| HeLa Cells | 5 | 2011 | 3073 | 0.050 |
Why?
|
| Phosphatidic Acids | 2 | 1994 | 50 | 0.050 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 1132 | 0.050 |
Why?
|
| Ribonucleoproteins | 1 | 2005 | 358 | 0.050 |
Why?
|
| Multiprotein Complexes | 1 | 2009 | 1110 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2009 | 1197 | 0.050 |
Why?
|
| Immunosuppressive Agents | 2 | 2006 | 4210 | 0.050 |
Why?
|
| Polymerization | 2 | 2013 | 154 | 0.050 |
Why?
|
| Binding Sites | 3 | 2013 | 6014 | 0.050 |
Why?
|
| Immunity, Innate | 3 | 2009 | 3076 | 0.050 |
Why?
|
| Pedigree | 3 | 2016 | 4539 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 2 | 2003 | 1081 | 0.050 |
Why?
|
| Hydroxyurea | 2 | 2007 | 284 | 0.050 |
Why?
|
| Carbocyanines | 3 | 1996 | 177 | 0.050 |
Why?
|
| RNA, Messenger, Stored | 1 | 2000 | 5 | 0.050 |
Why?
|
| Respiratory Tract Infections | 1 | 2009 | 1009 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2012 | 3139 | 0.050 |
Why?
|
| Immunoblotting | 4 | 2012 | 1647 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2008 | 1801 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 1027 | 0.050 |
Why?
|
| Cell Size | 2 | 1993 | 624 | 0.040 |
Why?
|
| Liposomes | 3 | 1996 | 787 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 8 | 1996 | 9245 | 0.040 |
Why?
|
| Stress, Mechanical | 2 | 2015 | 1673 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2007 | 1368 | 0.040 |
Why?
|
| Mice, Inbred Strains | 2 | 2007 | 1765 | 0.040 |
Why?
|
| Feedback | 1 | 2004 | 797 | 0.040 |
Why?
|
| Ion Transport | 3 | 1999 | 322 | 0.040 |
Why?
|
| Infant Food | 1 | 2000 | 139 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2012 | 3561 | 0.040 |
Why?
|
| Escherichia coli Proteins | 1 | 2007 | 1055 | 0.040 |
Why?
|
| Genotype | 1 | 2014 | 13035 | 0.040 |
Why?
|
| Oligopeptides | 1 | 2005 | 1195 | 0.040 |
Why?
|
| Spectrometry, Fluorescence | 3 | 1998 | 694 | 0.040 |
Why?
|
| Lamin Type A | 2 | 2013 | 187 | 0.040 |
Why?
|
| RNA-Binding Proteins | 3 | 2011 | 1889 | 0.040 |
Why?
|
| Extracellular Space | 1 | 2002 | 563 | 0.040 |
Why?
|
| Posture | 1 | 2004 | 956 | 0.040 |
Why?
|
| Chloramphenicol | 1 | 1999 | 67 | 0.040 |
Why?
|
| Actins | 3 | 2006 | 2059 | 0.040 |
Why?
|
| Epitopes | 1 | 2006 | 2526 | 0.040 |
Why?
|
| Cell Nucleus | 4 | 2013 | 2875 | 0.040 |
Why?
|
| Insulin | 3 | 2008 | 6602 | 0.040 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1999 | 187 | 0.040 |
Why?
|
| Rhodamines | 2 | 1991 | 179 | 0.040 |
Why?
|
| Aquaporin 1 | 1 | 1999 | 59 | 0.040 |
Why?
|
| Integrin alpha Chains | 1 | 1999 | 93 | 0.040 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 1998 | 70 | 0.040 |
Why?
|
| Receptors, Bradykinin | 1 | 1998 | 19 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2004 | 1145 | 0.040 |
Why?
|
| Electromyography | 1 | 2004 | 1398 | 0.040 |
Why?
|
| Antigens, Bacterial | 2 | 1995 | 1148 | 0.040 |
Why?
|
| Aniline Compounds | 2 | 1995 | 1080 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2007 | 3804 | 0.040 |
Why?
|
| Hand | 1 | 2004 | 910 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2005 | 3511 | 0.040 |
Why?
|
| Cell Line, Transformed | 2 | 2012 | 861 | 0.040 |
Why?
|
| Phenotype | 3 | 2014 | 16718 | 0.040 |
Why?
|
| Laminin | 1 | 2000 | 404 | 0.040 |
Why?
|
| Salmonella typhi | 1 | 2000 | 200 | 0.040 |
Why?
|
| Bradykinin | 1 | 1998 | 205 | 0.040 |
Why?
|
| Ceramides | 1 | 1999 | 202 | 0.040 |
Why?
|
| Erythroblasts | 1 | 1998 | 141 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2019 | 266 | 0.040 |
Why?
|
| Software | 1 | 2012 | 4472 | 0.040 |
Why?
|
| Asia, Southeastern | 2 | 1995 | 115 | 0.040 |
Why?
|
| NF-kappa B | 2 | 2007 | 2493 | 0.040 |
Why?
|
| Cricetinae | 3 | 2004 | 2415 | 0.040 |
Why?
|
| Mitochondria | 2 | 2002 | 3678 | 0.040 |
Why?
|
| Membrane Potentials | 3 | 2002 | 1085 | 0.040 |
Why?
|
| Interleukin-2 | 3 | 2004 | 1894 | 0.040 |
Why?
|
| Blood Group Antigens | 1 | 1999 | 183 | 0.040 |
Why?
|
| Enzyme Activation | 5 | 2004 | 3587 | 0.040 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 1998 | 185 | 0.040 |
Why?
|
| Lipopolysaccharides | 2 | 2002 | 2217 | 0.040 |
Why?
|
| Hemoglobin SC Disease | 1 | 1996 | 23 | 0.030 |
Why?
|
| Cell Survival | 2 | 1997 | 5750 | 0.030 |
Why?
|
| Antigen-Antibody Reactions | 2 | 1995 | 341 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2004 | 2931 | 0.030 |
Why?
|
| Eye Color | 1 | 2016 | 35 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2007 | 1942 | 0.030 |
Why?
|
| Graft vs Host Disease | 3 | 1991 | 3049 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 1993 | 1442 | 0.030 |
Why?
|
| Receptors, CCR5 | 1 | 1999 | 491 | 0.030 |
Why?
|
| Ferritins | 1 | 1999 | 601 | 0.030 |
Why?
|
| Exocytosis | 2 | 1995 | 323 | 0.030 |
Why?
|
| Lasers | 1 | 2001 | 951 | 0.030 |
Why?
|
| Heinz Bodies | 1 | 1996 | 5 | 0.030 |
Why?
|
| Potassium | 3 | 1999 | 1314 | 0.030 |
Why?
|
| Vanadates | 1 | 1996 | 82 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2011 | 393 | 0.030 |
Why?
|
| P-Selectin | 2 | 1995 | 598 | 0.030 |
Why?
|
| Hair Color | 1 | 2016 | 131 | 0.030 |
Why?
|
| Leukotriene D4 | 1 | 1995 | 33 | 0.030 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2017 | 300 | 0.030 |
Why?
|
| Antigens, Surface | 2 | 1991 | 1617 | 0.030 |
Why?
|
| Nonmuscle Myosin Type IIA | 1 | 2015 | 28 | 0.030 |
Why?
|
| Fluorescence | 2 | 1996 | 751 | 0.030 |
Why?
|
| Peptide Fragments | 2 | 2007 | 5141 | 0.030 |
Why?
|
| Skin Physiological Phenomena | 1 | 1996 | 193 | 0.030 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1996 | 176 | 0.030 |
Why?
|
| Hemorheology | 1 | 1996 | 144 | 0.030 |
Why?
|
| Glass | 1 | 1996 | 116 | 0.030 |
Why?
|
| Receptor, Insulin | 2 | 2004 | 839 | 0.030 |
Why?
|
| Erythrocyte Deformability | 1 | 1995 | 55 | 0.030 |
Why?
|
| Diphosphates | 1 | 1995 | 89 | 0.030 |
Why?
|
| Leukotriene C4 | 1 | 1995 | 79 | 0.030 |
Why?
|
| Mutation | 4 | 2015 | 30211 | 0.030 |
Why?
|
| Cytosol | 2 | 1998 | 885 | 0.030 |
Why?
|
| Peptide Library | 2 | 2007 | 351 | 0.030 |
Why?
|
| Lumicolchicines | 1 | 1994 | 3 | 0.030 |
Why?
|
| Cytochalasins | 1 | 1994 | 19 | 0.030 |
Why?
|
| von Willebrand Factor | 2 | 1995 | 680 | 0.030 |
Why?
|
| Catalysis | 2 | 2007 | 766 | 0.030 |
Why?
|
| Bone Marrow Cells | 2 | 2012 | 2412 | 0.030 |
Why?
|
| Fetal Viability | 1 | 1994 | 23 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2003 | 1705 | 0.030 |
Why?
|
| Radioligand Assay | 1 | 1994 | 365 | 0.030 |
Why?
|
| Motor Activity | 1 | 2004 | 2713 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 1987 | 4787 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 1999 | 729 | 0.030 |
Why?
|
| RNA Viruses | 1 | 2015 | 110 | 0.030 |
Why?
|
| Caffeine | 1 | 1998 | 703 | 0.030 |
Why?
|
| Aorta | 3 | 2012 | 2045 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1995 | 354 | 0.030 |
Why?
|
| Polyribosomes | 2 | 2005 | 109 | 0.030 |
Why?
|
| Centrifugation, Zonal | 1 | 1993 | 14 | 0.030 |
Why?
|
| Neurons | 1 | 2013 | 9517 | 0.030 |
Why?
|
| Lymphoma, T-Cell | 1 | 1996 | 308 | 0.030 |
Why?
|
| Bacillus subtilis | 2 | 2007 | 356 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2014 | 24299 | 0.030 |
Why?
|
| Mesocricetus | 1 | 1993 | 256 | 0.030 |
Why?
|
| Population Dynamics | 1 | 2015 | 314 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1995 | 1430 | 0.030 |
Why?
|
| HEK293 Cells | 2 | 2012 | 4280 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2000 | 1806 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2000 | 2605 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 1993 | 323 | 0.030 |
Why?
|
| Plasma | 1 | 1996 | 583 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 2007 | 1750 | 0.020 |
Why?
|
| Time Factors | 6 | 2011 | 40154 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2000 | 1362 | 0.020 |
Why?
|
| Motion | 1 | 1996 | 784 | 0.020 |
Why?
|
| Electrophoresis | 1 | 2012 | 226 | 0.020 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2012 | 186 | 0.020 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 2011 | 36 | 0.020 |
Why?
|
| Thrombin | 1 | 1994 | 600 | 0.020 |
Why?
|
| Bone Marrow Purging | 1 | 1991 | 108 | 0.020 |
Why?
|
| Rats | 4 | 1997 | 23713 | 0.020 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2002 | 1911 | 0.020 |
Why?
|
| Hematologic Diseases | 1 | 1995 | 498 | 0.020 |
Why?
|
| Jews | 1 | 2013 | 359 | 0.020 |
Why?
|
| Spliceosomes | 1 | 2011 | 116 | 0.020 |
Why?
|
| Genome, Viral | 1 | 2015 | 673 | 0.020 |
Why?
|
| Molecular Sequence Data | 4 | 2013 | 17608 | 0.020 |
Why?
|
| Microcirculation | 1 | 1996 | 1282 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2013 | 515 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2007 | 4167 | 0.020 |
Why?
|
| Embryonic Development | 1 | 1996 | 722 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 1995 | 1472 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 1992 | 479 | 0.020 |
Why?
|
| Antibodies | 1 | 1999 | 2419 | 0.020 |
Why?
|
| Transforming Growth Factors | 1 | 1990 | 76 | 0.020 |
Why?
|
| Abortion, Spontaneous | 1 | 1996 | 534 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2019 | 2353 | 0.020 |
Why?
|
| TRPM Cation Channels | 1 | 2011 | 140 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2011 | 212 | 0.020 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2015 | 539 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2005 | 1989 | 0.020 |
Why?
|
| Erythrocyte Count | 1 | 2010 | 157 | 0.020 |
Why?
|
| Serine | 2 | 2006 | 828 | 0.020 |
Why?
|
| Carbon Monoxide | 1 | 1994 | 559 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 1130 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1996 | 976 | 0.020 |
Why?
|
| Haplotypes | 1 | 2016 | 2722 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 1993 | 1211 | 0.020 |
Why?
|
| Casein Kinase II | 1 | 2010 | 121 | 0.020 |
Why?
|
| TRPC Cation Channels | 1 | 2010 | 111 | 0.020 |
Why?
|
| Puerperal Infection | 1 | 1990 | 46 | 0.020 |
Why?
|
| Base Sequence | 3 | 2013 | 12414 | 0.020 |
Why?
|
| 4-Chloro-7-nitrobenzofurazan | 2 | 1996 | 21 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 1995 | 1250 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1992 | 457 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 1996 | 1676 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1994 | 1504 | 0.020 |
Why?
|
| Stochastic Processes | 1 | 2011 | 359 | 0.020 |
Why?
|
| Ribonuclease III | 1 | 2011 | 271 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 5794 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2012 | 598 | 0.020 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2010 | 238 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 5886 | 0.020 |
Why?
|
| Female | 13 | 2013 | 396660 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2008 | 5022 | 0.020 |
Why?
|
| Autoantigens | 1 | 1993 | 890 | 0.020 |
Why?
|
| Amino Acid Sequence | 4 | 2007 | 13411 | 0.020 |
Why?
|
| Ribonucleosides | 1 | 2009 | 79 | 0.020 |
Why?
|
| Wound Healing | 1 | 2000 | 2800 | 0.020 |
Why?
|
| Microtubules | 1 | 1994 | 1062 | 0.020 |
Why?
|
| Catenins | 1 | 2008 | 44 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2013 | 21178 | 0.020 |
Why?
|
| Phalloidine | 1 | 1988 | 21 | 0.020 |
Why?
|
| Meningitis | 1 | 1990 | 219 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2011 | 818 | 0.020 |
Why?
|
| Intracellular Membranes | 2 | 2002 | 386 | 0.020 |
Why?
|
| Melanocytes | 1 | 2011 | 509 | 0.020 |
Why?
|
| beta-Cyclodextrins | 1 | 2008 | 67 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 294 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2005 | 12158 | 0.020 |
Why?
|
| Phosphatidylcholines | 2 | 1996 | 405 | 0.020 |
Why?
|
| Thiocyanates | 1 | 1987 | 70 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 1994 | 2221 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2008 | 325 | 0.020 |
Why?
|
| Nitric Oxide | 2 | 2007 | 2140 | 0.020 |
Why?
|
| Action Potentials | 1 | 1995 | 1835 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 2394 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 1990 | 15824 | 0.020 |
Why?
|
| Half-Life | 1 | 2008 | 648 | 0.020 |
Why?
|
| Cell Separation | 1 | 1993 | 1717 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2016 | 2629 | 0.020 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2007 | 42 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2005 | 1677 | 0.020 |
Why?
|
| Diptera | 1 | 2007 | 50 | 0.020 |
Why?
|
| RNA Interference | 1 | 2015 | 2829 | 0.020 |
Why?
|
| Antisickling Agents | 1 | 2007 | 72 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 9612 | 0.020 |
Why?
|
| Gap Junctions | 1 | 2008 | 230 | 0.020 |
Why?
|
| Paclitaxel | 1 | 1994 | 1728 | 0.020 |
Why?
|
| Bacterial Adhesion | 1 | 2008 | 306 | 0.020 |
Why?
|
| Osmolar Concentration | 2 | 1994 | 654 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2013 | 20169 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1999 | 3408 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2008 | 580 | 0.020 |
Why?
|
| Megakaryocytes | 1 | 1990 | 557 | 0.020 |
Why?
|
| Male | 10 | 2013 | 364203 | 0.020 |
Why?
|
| Cell Communication | 1 | 1993 | 1660 | 0.020 |
Why?
|
| Protein Biosynthesis | 2 | 2005 | 2093 | 0.020 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 1988 | 260 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 1996 | 3227 | 0.020 |
Why?
|
| Endothelium | 1 | 2008 | 768 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2004 | 10748 | 0.020 |
Why?
|
| Cytokines | 1 | 2000 | 7446 | 0.020 |
Why?
|
| Reference Values | 1 | 1993 | 4918 | 0.020 |
Why?
|
| Streptococcal Infections | 1 | 1990 | 618 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1998 | 4405 | 0.020 |
Why?
|
| Mitosis | 1 | 1990 | 1176 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 17097 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2010 | 5891 | 0.010 |
Why?
|
| Adult | 8 | 2013 | 223317 | 0.010 |
Why?
|
| Biotin | 1 | 2006 | 255 | 0.010 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2007 | 348 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2010 | 1526 | 0.010 |
Why?
|
| Information Dissemination | 1 | 2013 | 1142 | 0.010 |
Why?
|
| Transferrin | 1 | 2005 | 283 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 59548 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 1993 | 2322 | 0.010 |
Why?
|
| Uterus | 1 | 1988 | 661 | 0.010 |
Why?
|
| Enzyme Inhibitors | 2 | 2006 | 3726 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1993 | 2428 | 0.010 |
Why?
|
| src-Family Kinases | 1 | 2006 | 539 | 0.010 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2004 | 136 | 0.010 |
Why?
|
| Cicatrix | 1 | 1990 | 798 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 1991 | 2710 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2000 | 4349 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1991 | 1814 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 2009 | 862 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2004 | 464 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1986 | 689 | 0.010 |
Why?
|
| Organic Chemicals | 1 | 2004 | 211 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2007 | 588 | 0.010 |
Why?
|
| Calcineurin | 1 | 2004 | 235 | 0.010 |
Why?
|
| Ruthenium Red | 1 | 2002 | 19 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1991 | 1083 | 0.010 |
Why?
|
| Calcimycin | 1 | 2002 | 214 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 474 | 0.010 |
Why?
|
| Myristic Acid | 1 | 2002 | 49 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2002 | 123 | 0.010 |
Why?
|
| Ionophores | 1 | 2002 | 108 | 0.010 |
Why?
|
| Blood Bactericidal Activity | 1 | 2002 | 124 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 478 | 0.010 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2007 | 582 | 0.010 |
Why?
|
| Oxadiazoles | 1 | 1982 | 94 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 6513 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2015 | 3070 | 0.010 |
Why?
|
| Sphingosine | 1 | 2004 | 306 | 0.010 |
Why?
|
| Tyrosine | 1 | 2006 | 1425 | 0.010 |
Why?
|
| Molecular Weight | 2 | 1996 | 2168 | 0.010 |
Why?
|
| NFATC Transcription Factors | 1 | 2004 | 393 | 0.010 |
Why?
|
| Lysophospholipids | 1 | 2004 | 336 | 0.010 |
Why?
|
| Palmitic Acid | 1 | 2002 | 148 | 0.010 |
Why?
|
| Dimyristoylphosphatidylcholine | 2 | 1996 | 26 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 816 | 0.010 |
Why?
|
| Albumins | 1 | 2004 | 577 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2004 | 778 | 0.010 |
Why?
|
| Emetine | 1 | 2000 | 15 | 0.010 |
Why?
|
| Puromycin | 1 | 2000 | 41 | 0.010 |
Why?
|
| HIV-1 | 1 | 1999 | 6951 | 0.010 |
Why?
|
| Peptides | 1 | 1993 | 4348 | 0.010 |
Why?
|
| Poly(A)-Binding Proteins | 1 | 2000 | 35 | 0.010 |
Why?
|
| GTP Phosphohydrolases | 1 | 2004 | 525 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2002 | 915 | 0.010 |
Why?
|
| Virus Replication | 1 | 2009 | 2457 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 1999 | 7469 | 0.010 |
Why?
|
| Stearic Acids | 1 | 2000 | 56 | 0.010 |
Why?
|
| Androstadienes | 1 | 2002 | 348 | 0.010 |
Why?
|
| Permeability | 1 | 2002 | 721 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2005 | 1743 | 0.010 |
Why?
|
| alpha-Linolenic Acid | 1 | 2000 | 144 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1998 | 11923 | 0.010 |
Why?
|
| Aconitate Hydratase | 1 | 1999 | 17 | 0.010 |
Why?
|
| Apoferritins | 1 | 1999 | 17 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2015 | 10455 | 0.010 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1999 | 74 | 0.010 |
Why?
|
| Iron-Regulatory Proteins | 1 | 1999 | 30 | 0.010 |
Why?
|
| Temperature | 2 | 1991 | 2232 | 0.010 |
Why?
|
| Linoleic Acid | 1 | 2000 | 158 | 0.010 |
Why?
|
| Lymphocyte Depletion | 2 | 1991 | 605 | 0.010 |
Why?
|
| Caspases | 1 | 2002 | 881 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 1244 | 0.010 |
Why?
|
| Hybridomas | 2 | 1992 | 442 | 0.010 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2000 | 225 | 0.010 |
Why?
|
| Iron-Sulfur Proteins | 1 | 1999 | 84 | 0.010 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 1998 | 24 | 0.010 |
Why?
|
| Ryanodine | 1 | 1998 | 46 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 2 | 1998 | 6067 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 2007 | 1161 | 0.010 |
Why?
|
| Muridae | 1 | 1998 | 55 | 0.010 |
Why?
|
| Microsomes | 1 | 1998 | 252 | 0.010 |
Why?
|
| Lung | 2 | 2007 | 10076 | 0.010 |
Why?
|
| Concanavalin A | 1 | 1998 | 189 | 0.010 |
Why?
|
| Necrosis | 1 | 2002 | 1614 | 0.010 |
Why?
|
| Cell Division | 2 | 1999 | 4473 | 0.010 |
Why?
|
| Mice, Knockout | 2 | 2007 | 14476 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 425 | 0.010 |
Why?
|
| K562 Cells | 1 | 1999 | 644 | 0.010 |
Why?
|
| Aged | 3 | 2013 | 171319 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2000 | 541 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1999 | 568 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 2268 | 0.010 |
Why?
|
| United States | 2 | 2017 | 72971 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 8628 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2000 | 1252 | 0.010 |
Why?
|
| S Phase | 1 | 1998 | 424 | 0.010 |
Why?
|
| Pregnancy | 4 | 1996 | 30238 | 0.010 |
Why?
|
| Dimerization | 1 | 1998 | 882 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 1999 | 655 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 18401 | 0.010 |
Why?
|
| Middle Aged | 3 | 2013 | 223233 | 0.010 |
Why?
|
| Membranes, Artificial | 1 | 1997 | 363 | 0.010 |
Why?
|
| Lymphocyte Cooperation | 1 | 1995 | 112 | 0.010 |
Why?
|
| Gene Targeting | 1 | 1999 | 841 | 0.010 |
Why?
|
| Ethanolamines | 1 | 1996 | 152 | 0.010 |
Why?
|
| Dogs | 1 | 2000 | 3834 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2007 | 4209 | 0.010 |
Why?
|
| Surface Properties | 1 | 1997 | 1154 | 0.010 |
Why?
|
| Phosphatidylserines | 1 | 1996 | 186 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2006 | 3044 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1995 | 456 | 0.010 |
Why?
|
| Electroporation | 1 | 1995 | 238 | 0.010 |
Why?
|
| Fetal Hemoglobin | 1 | 1996 | 346 | 0.010 |
Why?
|
| Sodium | 1 | 1999 | 1594 | 0.010 |
Why?
|
| Docosahexaenoic Acids | 1 | 2000 | 914 | 0.010 |
Why?
|
| Kidney | 2 | 2000 | 7063 | 0.010 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1994 | 282 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 1993 | 333 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2006 | 4925 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1993 | 1141 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1998 | 2509 | 0.010 |
Why?
|
| Enterotoxins | 1 | 1993 | 366 | 0.010 |
Why?
|
| Video Recording | 1 | 1996 | 977 | 0.010 |
Why?
|
| Blood Protein Electrophoresis | 1 | 1990 | 65 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1991 | 439 | 0.010 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2000 | 1399 | 0.010 |
Why?
|
| DNA Replication | 1 | 1998 | 1426 | 0.010 |
Why?
|
| Glycolipids | 1 | 1991 | 203 | 0.010 |
Why?
|
| Ligands | 1 | 1997 | 3273 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 1991 | 280 | 0.010 |
Why?
|
| CHO Cells | 1 | 1993 | 1376 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 1999 | 22361 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1999 | 2204 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1996 | 1531 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 1729 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 18330 | 0.000 |
Why?
|
| Streptococcus agalactiae | 1 | 1990 | 337 | 0.000 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1991 | 527 | 0.000 |
Why?
|
| Cell Differentiation | 2 | 1998 | 11657 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1996 | 3684 | 0.000 |
Why?
|
| Apoptosis | 1 | 2002 | 9513 | 0.000 |
Why?
|
| Obstetric Labor, Premature | 1 | 1988 | 268 | 0.000 |
Why?
|
| Antigens, Differentiation | 1 | 1989 | 920 | 0.000 |
Why?
|
| Spleen | 1 | 1991 | 2292 | 0.000 |
Why?
|
| Immunoenzyme Techniques | 1 | 1988 | 1697 | 0.000 |
Why?
|
| Staphylococcus aureus | 1 | 1993 | 1429 | 0.000 |
Why?
|
| Puerperal Disorders | 1 | 1988 | 304 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 1998 | 7611 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2000 | 8940 | 0.000 |
Why?
|
| Leukemia | 1 | 1991 | 1518 | 0.000 |
Why?
|
| Skin | 1 | 1996 | 4499 | 0.000 |
Why?
|
| Graft Survival | 1 | 1991 | 3896 | 0.000 |
Why?
|
| Infant | 1 | 2000 | 36485 | 0.000 |
Why?
|
| Prostatic Neoplasms | 1 | 2000 | 11097 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1988 | 6000 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1988 | 11063 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 1988 | 14766 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1988 | 54886 | 0.000 |
Why?
|
| Adolescent | 1 | 1991 | 89046 | 0.000 |
Why?
|